Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. E.M.D. (Ed) Schuuring
University Medical Center Groningen

prof. dr. E.M.D. (Ed) Schuuring

Hoogleraar in de Moleculaire Oncologische Pathologie
Profielfoto van prof. dr. E.M.D. (Ed) Schuuring
E-mail:
e.schuuring umcg.nl

Publicaties

Clinical validation of a three-marker methylation panel to detect CIN3+ in vaginal self-samples in the Dutch population-based screening programme

Corrigendum to "Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands" [Eur J Cancer 205 (2024)114125]

Large language model-based approach for low-cost, rapid and accurate automated extraction of predictive biomarker testing results from Dutch pathology reports

Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number Profiling

Trends in cervical cancer incidence in the Netherlands: A join-point and age–period–cohort analysis (1989–2023)

Young women with (pre)malignant cervical disease in northern Netherlands: what characterises them - A population-based cohort study

Authors' Reply “Non-Smoking and Non-Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours”

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study

Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib

Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing

Pers/media

Pompepenning voor Ed Schuuring

Trouw Nieuwe test om baarmoederhalskanker op te sporen

Onderzoekers vinden nieuwe test om baarmoederhalskanker op te sporen: ‘Beter en vrouwvriendelijker’

Nieuwe Groningse test voorkomt duizenden fouten bij opsporen baarmoederhalskanker

European Liquid Biopsy Society geeft advies over de rapportage van ctDNA-testuitslagen

Highlights cfDNA

De praktische meerwaarde van de KNT-lijsten.

Delivering molecular pathology at lower costs

Dynamische lijsten voor testen op targets.

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 7 – Betaalbare en schone energieSDG 9 – Industrie, innovatie en infrastructuurSDG 12 – Verantwoordelijke consumptie en productie

Meer informatie over de Sustainable Development Goals.